Zeo Scientifix Inc (BPSR) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Zeo Scientifix Inc   (BPSR)
 

Zeo Scientifix Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Zeo Scientifix Inc 's inventory turnover ratio sequentially decreased to 2.76 in the second quarter 2026, unsurprisingly, as the Zeo Scientifix Inc markets continue to deteriorate, and BPSR's faces growing challenges to bring down its inventories. Zeo Scientifix Inc 's average inventory processing period in the Apr 30 2026 quarter, has increased to 132 days, from 127 days, in the Jan 31 2026 quarter.

Within Healthcare sector 144 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1020 in the first quarter 2026, to 1200.

BPSR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Zeo Scientifix Inc Market Share?

What is Inventory Turnover Ratio?




BPSR Inventory Turnover Ratio (Apr 30 2026)
II. Quarter
(Jan 31 2026)
I. Quarter
(Oct 31 2025)
IV. Quarter
(Jul 31 2025)
III. Quarter
(Apr 30 2025)
II. Quarter
Y / Y Inventory Growth 191.91 % 104.9 % 82.33 % 3.2 % -13.6 %
Y / Y Cost of Sales Growth 105.47 % 47.12 % 13.78 % 29.55 % -9.86 %
Inventory Turnover Ratio (TTM) 2.76 2.88 3.21 3.71 3.53
BPSR's Total Ranking # 1200 # 1020 # 1106 # 890 # 1020
Average inventory processing period 132 127 114 98 104
Seq. Inventory Growth 36.65 % 18.68 % 63.95 % 9.79 % -4.08 %
Seq. Cost of Sales Growth 87.19 % 9.77 % 12.28 % -10.94 % 34.03 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 145
Overall Market # 1200

Inventory Turnover Ratio Statistics
High Average Low
23.33 5.96 1.26
(Jul 31 2016)   (Jul 31 2017)




Financial Statements
Zeo Scientifix Inc 's Inventories $ 1 Millions Visit BPSR's Balance sheet
Zeo Scientifix Inc 's Cost of Revenues TTM $ 1 Millions Visit BPSR's Income Statement
What are BPSR's Sales? Visit BPSR's Sales by Segment

Other Inventory Turnover Ratios
Zeo Scientifix Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BPSR's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BPSR's Competitors
Inventory Turnover Ratio for BPSR's Suppliers
Inventory Turnover Ratio for BPSR's Customers

You may also want to know
BPSR's Sales Growth Rates BPSR's Pe Price to earnings ratio BPSR's Receivables Turnover Ratio BPSR's Stock Quote
BPSR's Net Income Growth Rates BPSR's Ps Price to Sales ratio BPSR's Sales per Employee BPSR's Asset Turnover Ratio
BPSR's Net Margin BPSR's Pb Price to Book ratio BPSR's Financial Strength Ratios BPSR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Apr 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Apr 30 2026 Inventories at quarter ending Apr 30 2026
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions
Tactile Systems Technology Inc   5.08 $ 81.000  Millions$ 16  Millions
Integrated Biopharma Inc  4.96 $ 45.000  Millions$ 9  Millions
Ufp Technologies Inc   4.95 $ 436.000  Millions$ 88  Millions
Polomar Health Services, Inc.  4.79 $ 0.642  Millions$ 0  Millions
Henry Schein Inc   4.70 $ 9,209.000  Millions$ 1,959  Millions
Bionexus Gene Lab Corp   4.70 $ 4.191  Millions$ 1  Millions
Medinotec Inc   4.69 $ 4.864  Millions$ 1  Millions
West Pharmaceutical Services Inc   4.68 $ 2,052.000  Millions$ 439  Millions
Scilex Holding Company  4.48 $ 14.462  Millions$ 3  Millions
Guardant Health Inc   4.41 $ 379.203  Millions$ 86  Millions
Idexx Laboratories Inc  4.38 $ 1,690.942  Millions$ 386  Millions
Envista Holdings Corporation  4.36 $ 1,267.000  Millions$ 290  Millions
Inotiv Inc   4.25 $ 175.895  Millions$ 41  Millions
Cryoport inc   4.23 $ 96.609  Millions$ 23  Millions
Teva Pharmaceutical Industries Limited  4.22 $ 8,317.000  Millions$ 1,971  Millions
Incyte Corporation  4.21 $ 403.465  Millions$ 96  Millions
Electromed Inc   4.16 $ 14.195  Millions$ 3  Millions
Vericel Corporation  4.15 $ 73.494  Millions$ 18  Millions
Sharps Technology Inc   4.12 $ 3.585  Millions$ 1  Millions
Coherus Oncology inc   4.11 $ 14.975  Millions$ 4  Millions
Novocure Limited  4.08 $ 167.287  Millions$ 41  Millions
Lifeward ltd   4.08 $ 13.275  Millions$ 3  Millions
Ge Healthcare Technologies Inc   4.04 $ 9,262.000  Millions$ 2,294  Millions
Koru Medical Systems Inc   3.99 $ 16.468  Millions$ 4  Millions
3m Company  3.94 $ 15,087.000  Millions$ 3,830  Millions
Iridex Corp  3.92 $ 32.247  Millions$ 8  Millions
Myomo Inc   3.88 $ 14.000  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.84 $ 71.976  Millions$ 19  Millions

Date modified: 2026-06-16T10:26:32+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.